PL365198A1 - Przeciwpikornawirusowe związki i środki, ich zastosowanie farmaceutyczne i substancje do ich wytwarzania - Google Patents
Przeciwpikornawirusowe związki i środki, ich zastosowanie farmaceutyczne i substancje do ich wytwarzaniaInfo
- Publication number
- PL365198A1 PL365198A1 PL01365198A PL36519801A PL365198A1 PL 365198 A1 PL365198 A1 PL 365198A1 PL 01365198 A PL01365198 A PL 01365198A PL 36519801 A PL36519801 A PL 36519801A PL 365198 A1 PL365198 A1 PL 365198A1
- Authority
- PL
- Poland
- Prior art keywords
- synthesis
- compositions
- materials
- pharmaceutical uses
- antipicornaviral compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19779600P | 2000-04-14 | 2000-04-14 | |
US19849700P | 2000-04-18 | 2000-04-18 | |
PCT/US2001/012333 WO2001079167A2 (en) | 2000-04-14 | 2001-04-12 | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
Publications (1)
Publication Number | Publication Date |
---|---|
PL365198A1 true PL365198A1 (pl) | 2004-12-27 |
Family
ID=26893177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL01365198A PL365198A1 (pl) | 2000-04-14 | 2001-04-12 | Przeciwpikornawirusowe związki i środki, ich zastosowanie farmaceutyczne i substancje do ich wytwarzania |
Country Status (19)
Country | Link |
---|---|
US (3) | US6610730B2 (pl) |
EP (1) | EP1274682A2 (pl) |
JP (1) | JP2003531139A (pl) |
KR (1) | KR20030019350A (pl) |
CN (1) | CN1431995A (pl) |
AR (1) | AR028338A1 (pl) |
AU (1) | AU2001251639A1 (pl) |
BR (1) | BR0110077A (pl) |
CA (1) | CA2406475A1 (pl) |
HU (1) | HUP0300928A3 (pl) |
IL (1) | IL152243A0 (pl) |
MX (1) | MXPA02010195A (pl) |
PA (1) | PA8515201A1 (pl) |
PE (1) | PE20011277A1 (pl) |
PL (1) | PL365198A1 (pl) |
SV (1) | SV2001000379A (pl) |
UY (1) | UY26666A1 (pl) |
WO (1) | WO2001079167A2 (pl) |
ZA (1) | ZA200208257B (pl) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7064211B2 (en) | 2002-03-22 | 2006-06-20 | Eisai Co., Ltd. | Hemiasterlin derivatives and uses thereof |
KR101208266B1 (ko) | 2002-03-22 | 2012-12-05 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 헤미아스텔린 유도체 및 이의 용도 |
US7462594B2 (en) * | 2003-12-31 | 2008-12-09 | Taigen Biotechnology Co., Ltd. | Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases |
WO2005066123A1 (en) * | 2003-12-31 | 2005-07-21 | Taigen Biotechnology | Protease inhibitors |
KR100891699B1 (ko) | 2007-04-10 | 2009-04-03 | 광주과학기술원 | 7-아미노-4-((s)-3-(4-플루오로페닐)-2-((r)-3-메틸-2-(5-메틸이소옥사졸-3-카복사미도)부탄아미도)프로판아미도)-7-옥소-2-헵테노에이트 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 및 치료용 약학적 조성물 |
AU2009207634B2 (en) | 2008-01-25 | 2012-12-20 | Specialty Operations France | Use of ester amides as solvents, ester amides as such, and method for preparing ester amides |
US8450500B2 (en) | 2008-06-04 | 2013-05-28 | Synta Pharmaceuticals Corp. | Pyrrole compounds that modulate HSP90 activity |
EP3733672B1 (en) | 2017-12-25 | 2023-03-22 | Sumitomo Chemical Company, Limited | Heterocyclic compounds and noxious arthropod control agent containing same |
IL298324A (en) | 2020-06-10 | 2023-01-01 | Aligos Therapeutics Inc | Antiviral compounds for the treatment of coronavirus, picornavirus and novovirus infections |
WO2022156692A1 (zh) * | 2021-01-22 | 2022-07-28 | 中国人民解放军军事科学院军事医学研究院 | 一种环肽类病毒蛋白酶抑制剂,其制备方法,及其在抗病毒药物中的应用 |
WO2023283256A1 (en) | 2021-07-09 | 2023-01-12 | Aligos Therapeutics, Inc. | Anti-viral compounds |
WO2023043816A1 (en) | 2021-09-17 | 2023-03-23 | Aligos Therapeutics, Inc. | Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5374623A (en) * | 1992-08-20 | 1994-12-20 | Prototek, Inc. | Cysteine protease inhibitors effective for in vivo use |
US5486623A (en) | 1993-12-08 | 1996-01-23 | Prototek, Inc. | Cysteine protease inhibitors containing heterocyclic leaving groups |
IL112759A0 (en) | 1994-02-25 | 1995-05-26 | Khepri Pharmaceuticals Inc | Novel cysteine protease inhibitors |
IT1269511B (it) | 1994-05-17 | 1997-04-01 | Univ Degli Studi Milano | Derivati di acidi ammino-solfonici , loro impiego nella sintesi di pseudopeptidi e procedimento per la loro preparazione |
US5523312A (en) * | 1994-09-27 | 1996-06-04 | Sterling Winthrop Inc. | Antipicornaviral agents |
US5498616A (en) * | 1994-11-04 | 1996-03-12 | Cephalon, Inc. | Cysteine protease and serine protease inhibitors |
US6162828A (en) * | 1995-03-31 | 2000-12-19 | Takeda Chemical Industries, Ltd. | Cysteine protease inhibitor |
US5856530A (en) * | 1996-05-14 | 1999-01-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
AU722704B2 (en) | 1996-05-14 | 2000-08-10 | Agouron Pharmaceuticals, Inc. | Inhibitors of picornavirus 3c proteases and methods for their use and preparation |
WO1997049668A1 (en) | 1996-06-13 | 1997-12-31 | Smithkline Beecham Corporation | Inhibitiors of cysteine protease |
GB9615692D0 (en) * | 1996-07-25 | 1996-09-04 | Pharmacia Spa | Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
US6331554B1 (en) * | 1997-03-28 | 2001-12-18 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds, compositions containing them, and methods for their use |
WO1998043950A1 (en) * | 1997-03-28 | 1998-10-08 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compouds, compositions containing them, and methods for their use |
US6020371A (en) * | 1997-03-28 | 2000-02-01 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds compositions containing them and methods for their use |
US5962487A (en) * | 1997-12-16 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
CN1198838C (zh) | 1998-04-30 | 2005-04-27 | 阿格罗尼制药公司 | 抗小rna病毒化合物及其制备方法和用途 |
US6369226B1 (en) | 1999-06-21 | 2002-04-09 | Agouron Pharmaceuticals, Inc. | Substituted benzamide inhibitors of rhinovirus 3C protease |
ES2230135T3 (es) | 1999-08-04 | 2005-05-01 | Agouron Pharmaceuticals, Inc. | Compuestos y composiciones anti-picornavirales; utilizaciones farmaceuticas y materiales utilizados para su sintesis. |
PE20010517A1 (es) | 1999-08-24 | 2001-05-16 | Agouron Pharma | Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus y los intermedios claves |
CA2376509A1 (en) | 1999-08-24 | 2001-03-01 | Agouron Pharmaceuticals, Inc. | Process and intermediates for the preparation of isoxazolecaroxamides and analogues |
PE20020157A1 (es) | 1999-12-03 | 2002-02-22 | Agouron Pharma | Compuestos derivados de piridona como inhibidores de proteasas de picornaviral 3c, composiciones, sus usos farmaceuticos y materiales para su sintesis |
HUP0301331A3 (en) * | 2000-06-14 | 2004-03-01 | Agouron Pharmaceuticals Inc La | Antipicornaviral compounds process for their preparation and compositions containing them, their pharmaceutical uses, and intermediates for their synthesis |
-
2001
- 2001-04-11 PA PA20018515201A patent/PA8515201A1/es unknown
- 2001-04-11 PE PE2001000336A patent/PE20011277A1/es not_active Application Discontinuation
- 2001-04-12 BR BR0110077-7A patent/BR0110077A/pt not_active IP Right Cessation
- 2001-04-12 KR KR1020027013804A patent/KR20030019350A/ko not_active Application Discontinuation
- 2001-04-12 CN CN01810359A patent/CN1431995A/zh active Pending
- 2001-04-12 JP JP2001576769A patent/JP2003531139A/ja active Pending
- 2001-04-12 US US09/834,783 patent/US6610730B2/en not_active Expired - Fee Related
- 2001-04-12 IL IL15224301A patent/IL152243A0/xx unknown
- 2001-04-12 EP EP01925037A patent/EP1274682A2/en not_active Withdrawn
- 2001-04-12 AU AU2001251639A patent/AU2001251639A1/en not_active Abandoned
- 2001-04-12 CA CA002406475A patent/CA2406475A1/en not_active Abandoned
- 2001-04-12 PL PL01365198A patent/PL365198A1/pl not_active Application Discontinuation
- 2001-04-12 WO PCT/US2001/012333 patent/WO2001079167A2/en not_active Application Discontinuation
- 2001-04-12 MX MXPA02010195A patent/MXPA02010195A/es unknown
- 2001-04-12 HU HU0300928A patent/HUP0300928A3/hu unknown
- 2001-04-16 UY UY26666A patent/UY26666A1/es unknown
- 2001-04-17 SV SV2001000379A patent/SV2001000379A/es not_active Application Discontinuation
- 2001-04-17 AR ARP010101775A patent/AR028338A1/es not_active Application Discontinuation
-
2002
- 2002-10-14 ZA ZA200208257A patent/ZA200208257B/en unknown
-
2003
- 2003-05-12 US US10/435,082 patent/US6872745B2/en not_active Expired - Fee Related
-
2004
- 2004-11-12 US US10/986,109 patent/US20050101651A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SV2001000379A (es) | 2001-10-16 |
PA8515201A1 (es) | 2002-10-24 |
WO2001079167A3 (en) | 2002-02-28 |
PE20011277A1 (es) | 2002-01-07 |
US6872745B2 (en) | 2005-03-29 |
MXPA02010195A (es) | 2003-04-25 |
ZA200208257B (en) | 2003-07-25 |
UY26666A1 (es) | 2001-11-30 |
AU2001251639A1 (en) | 2001-10-30 |
HUP0300928A2 (hu) | 2003-08-28 |
AR028338A1 (es) | 2003-05-07 |
HUP0300928A3 (en) | 2005-08-29 |
EP1274682A2 (en) | 2003-01-15 |
BR0110077A (pt) | 2003-06-17 |
US20050101651A1 (en) | 2005-05-12 |
CN1431995A (zh) | 2003-07-23 |
US6610730B2 (en) | 2003-08-26 |
KR20030019350A (ko) | 2003-03-06 |
WO2001079167A2 (en) | 2001-10-25 |
US20020006943A1 (en) | 2002-01-17 |
US20030225042A1 (en) | 2003-12-04 |
CA2406475A1 (en) | 2001-10-25 |
JP2003531139A (ja) | 2003-10-21 |
IL152243A0 (en) | 2003-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0203108A3 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
EG24357A (en) | New Pharmaceutical composition | |
IL152659A0 (en) | Pharmaceutical composition | |
HK1075889A1 (en) | Pharmaceutical composition | |
DZ3313A1 (fr) | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant | |
HUP0400636A3 (en) | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof | |
HU0003111D0 (en) | Pharmaceutical compositions | |
HUP0204555A3 (en) | Pharmaceutical composition | |
IL149427A0 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
IL153428A0 (en) | Solid valsartan pharmaceutical compositions | |
IL152243A0 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
IL154238A0 (en) | Pharmaceutical composition | |
HUP0203275A3 (en) | 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants | |
IL153431A0 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
GB0005382D0 (en) | Pharmaceutical composition | |
SI1206484T1 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
ZA993000B (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis. | |
GB0101094D0 (en) | Pharmaceutical composition | |
GB0002691D0 (en) | Pharmaceutical composition | |
GB0027375D0 (en) | Pharmaceutical composition | |
GB0019599D0 (en) | Pharmaceutical composition | |
GB0016684D0 (en) | Pharmaceutical composition | |
GB0006301D0 (en) | Pharmaceutical composition | |
GB0026716D0 (en) | Pharmaceutical composition | |
HU0000060D0 (en) | Novel pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |